… chronic obstructive pulmonary disease (COPD) commonly involves long‐acting bronchodilators
including beta‐agonists (… ) is a common respiratory condition associated with substantial …

… Inhaled corticosteroids and FDCs were often used … inclusion of chronic obstructive pulmonary
disease (COPD), … insights into the relationship between the use of short- and long-acting …

… For the treatment of chronic obstructive pulmonary disease (COPD), long‐acting muscarinic
antagonists plus long‐acting beta‐agonists (LAMA+LABA) are associated with fewer …

… , use of ICS/LABA in a single inhaler was associated with lowered risk of all-cause mortality
… Both ICS and long-acting beta-agonists (LABAs) have been shown to be effective in COPD [3…

… adherence, but in terms of their attitudes regarding the patient-physician relationship. … 382)
reported no concomitant COPD, chronic bronchitis or emphysema and constituted the sample …

… COPD, long-acting beta-agonists (LABAs), long-acting muscarinic antagonists (LAMAs), and
… Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. Curr …

… as inhaled long acting β2 agonists (LABAs) and anti inflammatory drugs such as inhaled
corticosteroids … association between age, obesity, and smoking and the level of disease control. …

… of short-acting beta-agonists during the 12 months before … , we compared the associations
between the exposure and … is associated with higher risk of death in patients with COPD (…

… 90 days prior to and 30 days after the index hospitalization for COPD. Our hypothesis is
that use of maintenance drugs is associated with a reduction in the 30-day readmission rate. …

… outcome associated with not discontinuing long-acting bronchodilators … long-acting
beta-agonists (LABAs), alone or in combination with inhaled corticosteroids (ICS), and long-acting …